Genome wide mapping of UBF binding-sites in mouse and human cell lines  by Diesch, Jeannine et al.
Genomics Data 3 (2015) 103–105
Contents lists available at ScienceDirect
Genomics Data
j ou rna l homepage: ht tp : / /www. journa ls .e lsev ie r .com/genomics-data /Data in BriefGenome wide mapping of UBF binding-sites in mouse and human
cell linesJeannine Diesch a,b, Ross D. Hannan a,b,c,d,e,f, Elaine Sanij a,b,g,⁎
a Division of Cancer Research, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria 3002, Australia
b Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3010, Australia
c Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria 3800, Australia
d Department of Biochemistry and Molecular Biology, University of Melbourne, Parkville, Victoria 3010, Australia
e Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria 3002, Australia
f School of Biomedical Sciences, University of Queensland, Brisbane, Queensland 4072, Australia
g Department of Pathology, University of Melbourne, Parkville, Victoria 3010, Australia⁎ Corresponding author at: Growth Control Labora
MacCallum Cancer Centre, St Andrews Place, East Melbo
Tel.: +61 3 9656 3758; fax: +61 3 9656 3738.
E-mail address: elaine.sanij@petermac.org (E. Sanij).
Speciﬁcations
Organism/cell
line/tissue
Murine/NIH3T3; Homo sapie
lines HMEC and HMLER
Sex Male or female
Sequencer or array type Illumina Genome Analyzer II
Mouse Exon ST 1.0 arrays
Data format Raw ChIP-seq data: FASTQ ﬁ
TXT data; Microarray expres
Experimental factors The use of antibodies for Ch
RNA oligos for knocking dow
Experimental features ChIP-seq and microarray exp
Consent NA
Sample source location NA
http://dx.doi.org/10.1016/j.gdata.2014.12.005
2213-5960/© 2015 The Authors. Published by Elsevier Inca b s t r a c ta r t i c l e i n f oArticle history:
Received 16 December 2014
Accepted 29 December 2014
Available online 6 January 2015
Keywords:
UBF
RNA polymerase I
Histone modiﬁcations
ChIP-seqThe upstream binding transcription factor (UBTF, also called UBF) is thought to function exclusively in
RNA polymerase I (Pol I)-speciﬁc transcription of the ribosomal genes. We recently reported in Sanij et al.
(2014) [1] that the two isoforms of UBF (UBF1/2) are enriched at Pol II-transcribed genes throughout the
mouse and human genomes. By using chromatin immunoprecipitation coupled with deep sequencing
(ChIP-seq) of UBF1/2, Pol I, Pol II, H3K9me3, H3K4me4, H3K9ac and H4 hyperacetylation, we reported a
correlation of UBF1/2 binding with enrichments in Pol II and markers of active chromatin. In addition, we
examined a functional role for UBF1/2 in mediating Pol II transcription by performing expression array
analysis in control and UBF1/2 depleted NIH3T3 cells. Our data demonstrate that UBF1/2 bind highly active
Pol II-transcribed genes and mediate their expression without recruiting Pol I. Furthermore, we reported
ChIP-sequencing analysis of UBF1/2 in immortalized human epithelial cells and their isogenicallymatched trans-
formed counterparts. Here we report the experimental design and the description of the ChIP-sequencing
and microarray expression datasets uploaded to NCBI Sequence Research Archive (SRA) and Gene Expression
Omnibus (GEO).
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).ns/mammary epithelial cell
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. This is an open access article underDirect link to deposited data
Raw ChIP-seq data is available through the NCBI Sequence Read
Archive (SRA, http://www.ncbi.nlm.nih.gov/sra/), study accession num-
ber (SRP039369). Processed ChIP-seq data and microarray expression
data are available through the Gene Expression Omnibus (GEO, http://
www.ncbi.nlm.nih.gov/geo/), study accession number (GSE63255) and
(GSE55461), respectively.
Experimental design, materials and methods
Cell culture and RNA interference (RNAi) experiments
Mouse NIH3T3 cells (post-crisis, immortalized embryonic ﬁbroblasts,
ATCC) were cultured in Dulbecco's modiﬁed Eagle's medium (DMEM)
with 10% fetal bovine serum at 37 °C. The human primary mammary
epithelial cell line (HMEC) immortalized by expressing TERT, the cata-
lytic subunit of telomerase and the tumorigenic HMLER cell line, an iso-
genic HMEC-derived cell line expressing the SV40 large-T, TERT, and anthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cultured in HuMEC ready medium (12752010, life technologies).
Dharmafect 2 reagent (Dharmacon) was used to transfect NIH3T3
cells with siRNA at 40 nM according to the manufacturer's protocol.
RNA was extracted 48 h after transfection using Qiagen RNA extraction
kit. The short interfering RNA (siRNA) oligonucleotide RNA sequences
are reported in Sanij et al.[1].
Antibodies
Anti-H3K9me3 (ab8898), anti-H3K4me3 (ab8580), and anti-RNA
Pol II [4H8] (ab5408) antibodies were obtained from Abcam. Anti-
hyperacetylated H4 (06-946) and anti H3K9ac (07-352) antibodies
were from Upstate (Millipore). Antibodies targeting UBF1/2 and the
largest subunit of the Pol I complex (POLR1A/RPA194) were raised in-
house and were used as reported in Sanij et al.[3].
Chromatin immunoprecipitation
ChIP was carried out as described [4]. Cross-linking was achieved
with 0.6% formaldehyde for 10 min at 37 °C. The reaction was stopped
by adding 0.125 M glycine and cells were collected and washed with
PBS. Cell pellets were resuspended in 10 mM Tris pH 7.4, 10 mM NaCl,
10mMMgCl2, 0.5% NP-40 and protease inhibitor cocktail and incubated
on ice for 10min. The suspensionswere centrifuged and pelletswere re-
suspended in SDS lysis buffer (50 mM Tris pH 8.1, 10 mM EDTA, 1% SDS
and protease inhibitor cocktail) at 4 × 106 cells per 300 μl. Sonication
was performed using Covaris (Covaris Inc) for 25 min at (Duty cycle
20%, intensity 5, cycles per burst 200; 30 s ON, 30 s OFF) to obtain chro-
matin shearing range between 200–400 base pairs.
Sonicated chromatin was centrifuged at 13,000 rpm for 10 min at
4 °C and supernatants were collected for immunoprecipitation (IP).
150 μl of lysates corresponding to 2 × 106 cells per IP was diluted
to 1.5 ml with IP dilution buffer (1 mM DTT, 0.01% SDS, 1.1% Triton
X-100, 1.2 mM EDTA, 16.7 mM Tris pH 8.1, 167 mM NaCl and protease
inhibitor cocktail) and 120 μl was used as reference (8% of input geno-
mic DNA (gDNA)). The lysates were precleared with 35 μl of protein A
agarose/salmon sperm DNA (Upstate, Millipore). For all ChIPs, 4 μg of
puriﬁed antibody or 8 μl of sera was used per IP and incubated over-
night at 4 °C with rotation. 50 μl of protein A agarose/salmon sperm
DNA beads was added per tube and incubated for 2 h at 4 °C with rota-
tion. Beads were washed sequentially with three different wash buffers
and two washed in TE buffer for 5 min at 4 °C with rotation (low salt
wash buffer: 20 mM Tris pH 8.1, 2 mM EDTA, 1% Triton X-100, 0.1%
SDS, 150 mM NaCl; high salt wash buffer: 20 mM Tris pH 8.1, 2 mM
EDTA, 1% Triton X-100, 0.1% SDS, 500 mM NaCl; LiCl wash buffer:
10 mM Tris pH 8, 1 mM EDTA, 0.25 M LiCl, 0.5% NP-40, 0.5%
Deoxycholate (sodium salt); TE buffer: 10 mM Tris pH 8, 1 mM EDTA).
The immunoprecipitated chromatin was eluted twice with 250 μl elu-
tion buffer (1% SDS, 0.1 M NaHCO3) with rotation for 15 min at room
temperature. 20 μl of 5 M NaCl was added and samples were incubated
at 65 °C overnight to reverse protein–DNA crosslinking. Protein K diges-
tion was then performed and DNA was extracted using (1:1) phenol:
chloroform extraction followed by isopropanol precipitation. The % of
immunoprecipitated DNA was calculated relative to the reference
gDNA input. The quality of enrichments in binding was measured rela-
tive to rabbit sera ChIP controls.
DNA concentration was measured with the Qubit dsDNA HS assay
kit (Invitrogen).
Sequencing experiments
Sequencing libraries of 10–30 ηg of ChIPed DNA and input gDNA
were prepared using the TruSeq ChIP sample preparation kit as
per manufacturer's protocol (Illumina, San Diego, CA, USA). NIH3T3
ChIP-seq libraries (UBF1/2, Pol I, Pol II, H3K4me3, H3K9me3, H3K9ac,H4 hyperacetylation, gDNA) and HMEC ChIP-seq libraries (UBF1/2,
Pol I, gDNA) were sequenced using the Illumina Genome Analyzer II
platform at the Peter MacCallum Cancer Centre, while HMLER ChIP-
seq libraries of UBF1/2 and gDNA were performed using Illumina
HiSeq 1000.
Base calling was performed using CASAVA-1.8.2 (Illumina) with de-
fault parameters and sequencing reads mapped to the mouse mm9 or
human hg19 genome assembly using the Burrows–Wheeler Aligner
(BWA) [5]. After removing duplicate reads with Picard tools, peaks
over input gDNA were called using MACS1.4 (Model-based Analysis of
ChIP-seq) [6]. Normalized fold change was calculated for each peak
and summit using theBioconductor R package [7] and peakswere anno-
tated to RefSeq genes using the R package ChIPpeakAnno [8].
Quality control and functional annotation
Only peak regions with a FDR below 10% and p-value below 0.00001
were selected, and signiﬁcant peaks were validated by qPCR as recently
reported in Sanij et al.[1]. The Bioconductor R package and the Sole-
Search program [11] were used to determine the distribution of UBF1/2
peaks relative to RefSeq genes and their transcription start and termina-
tion sites (TSS and TTS).
Expression analysis
We performed microarray analysis (Affymetrix, Mouse Exon ST 1.0
arrays) on three biological replicates of UBF1/2 knockdown samples
using two independent siRNA oligos, a non-silencing sirEGFP or Mock
transfected NIH3T3 samples. The arrays were normalized using Robust
Multi-Array Average expression measure (RMA) [9] and differential
expression was then determined using a linear model and the Limma
package (http://bioinf.wehi.edu.au/limma/). Moderated t-statistics
were generated and signiﬁcance was assessed using log fold change
and an FDR (false discovery rate) adjusted p-value [10].
Correlation between expression values from themock NIH3T3 sam-
ples for all genes, genes with signiﬁcant UBF1/2 peaks b2 kb from their
TSS, or genes with no UBF1/2 binding at their TSS, was performed using
the R package and statistical signiﬁcance assessed using the t-tests.
Results
Genome-wide enrichment of UBF1/2 showed preference for binding
near TSSs, whereas no signiﬁcant binding preference was observed at
the TTSs. Almost 40% of all UBF1/2 binding overlapped with ﬁrst exons
and introns of annotated genes in mouse as well as human cells.
We intersected regions bound byUBF1/2with a variety of posttrans-
lational histone modiﬁcation binding sites as well as Pol II and Pol I
enriched regions in NIH3T3 cells. Overlapping peaks were deﬁned
as peaks with at least 1 bp overlap. While little correlation between
UBF1/2 binding and the presence of the transcriptional repressive
mark H3K9me3 was observed, almost 50% of the UBF1/2 peaks over-
lapped with the activating H3K4me3, H4K9ac and H4 hyperacetylation
marks and Pol II enrichment. Thus, UBF1/2 is preferably bound to open
chromatin structures associatedwith active promoters and gene bodies.
Furthermore, the comparison of UBF1/2 and Pol I ChIP-seq analysis in
NIH3T3 and HMEC cell lines revealed little overlap in binding (less
than 8% and 3%, respectively), demonstrating that UBF1/2 does not
recruit Pol I to Pol II genes.
We then investigated whether UBF1/2 binding correlatedwith tran-
scriptional activity by intersecting UBF1/2-bound genes with gene
expression data in NIH3T3 cells. This revealed that genes enriched in
UBF1/2 are expressed at high levels compared to non-UBF1/2 bound
genes and all transcribed genes in the genome. Gene ontology analysis
using the Genomic Regions Enrichment of Annotation Tool (GREAT)
[11] revealed chromatin assembly and nucleosome organization and
assembly as the biological processes most signiﬁcantly enriched with
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datasets.
To determine if UBF1/2 binding has a functional effect on gene
expression, we intersected the ChIP-seq and microarray expression
datasets and identiﬁed genes whose expression was signiﬁcantly
altered by UBF1/2 knockdown and were bound by UBF1/2 within
500 bp of their TSSs. Gene ontology analysis using the MetaCore path-
ways software (ThomsonReuters) identiﬁed a signiﬁcant overrepresen-
tation of genes belonging to chromatin/nucleosome assembly and DNA
packaging, including canonical histone genes and histone gene variants
indicating that their transcription may be directly regulated by UBF1/2.
In Sanij et al.[1], we further validated a novel role for UBF1/2 in medi-
ating Pol II transcription of histone genes.
Discussion
We recently reported a dual function for the Pol I transcription factor
UBF1/2 in the regulation of Pol I and Pol II mediated transcription [1]. In
addition, we described a fundamental role for UBF1/2 in regulating
highly transcribed Pol II genes, including the histone gene clusters.
Moreover, in the transformed HMLER cells, we demonstrated that
UBF1/2 is enriched at an additional cohort of genes involved in DNA
damage and repair including mediators of ATR/ATM-regulated DNA
damage response, signal transduction by TP53 and G1 to S transition
of cell cycle. Thus, UBF1/2 binding is dynamic, context dependent and
potentially associated with malignant transformation.
In summary, we demonstrated a fundamental role for UBF1/2
in coupling Pol I transcription and the cell's capacity to growwith the ﬁ-
delity of chromatin assembly through its ability to coordinately regulate
the expression of some of the most highly transcribed Pol I and Pol II
genes in the genome including the histone clusters and ribosomal
DNA repeats.Conﬂict of interest statement
We declare no conﬂict of interest.
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